Stephen W. Fesik
Corporate Officer/Principal at The Vanderbilt-Ingram Cancer Center
Profile
Stephen W.
Fesik is a Member at The Vanderbilt-Ingram Cancer Center, a Professor at Vanderbilt University School of Medicine, a Member at the Institute of Chemical Biology & Drug Discovery, and a Member at the Center For Structural Biology.
He is a former Independent Director at Bruker Corp., a former Director at Inhibikase Therapeutics, Inc., and a former Vice President-Cancer Research Division at Abbott Laboratories.
Fesik holds a doctorate degree from the University of Connecticut.
Stephen W. Fesik active positions
| Companies | Position | Start |
|---|---|---|
The Vanderbilt-Ingram Cancer Center
 The Vanderbilt-Ingram Cancer Center Hospital/Nursing ManagementHealth Services The Vanderbilt-Ingram Cancer Center engages in the prevention, diagnosis, and treatment of cancer. The non-profit company is based in Nashville, TN. | Corporate Officer/Principal | 2010-06-16 |
| Vanderbilt University School of Medicine | Corporate Officer/Principal | 2009-04-30 |
| Institute of Chemical Biology & Drug Discovery | Corporate Officer/Principal | - |
| Center For Structural Biology | Corporate Officer/Principal | - |
Former positions of Stephen W. Fesik
| Companies | Position | End |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
| INHIBIKASE THERAPEUTICS, INC. | Director/Board Member | - |
| BRUKER CORPORATION | Director/Board Member | - |
Training of Stephen W. Fesik
| University of Connecticut | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| BRUKER CORPORATION | Health Technology |
| INHIBIKASE THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
The Vanderbilt-Ingram Cancer Center
The Vanderbilt-Ingram Cancer Center Hospital/Nursing ManagementHealth Services The Vanderbilt-Ingram Cancer Center engages in the prevention, diagnosis, and treatment of cancer. The non-profit company is based in Nashville, TN. | Health Services |
| Institute of Chemical Biology & Drug Discovery | |
| Center For Structural Biology |
- Stock Market
- Insiders
- Stephen W. Fesik